If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGeorgia Capital Regulatory News (CGEO)

Share Price Information for Georgia Capital (CGEO)

Share Price is delayed by 15 minutes
Get Live Data
4,510.00    30.00 (0.67%)
Bid:
4,505.00
Ask:
4,540.00
Spread: 35.00 (0.777%)
Market Cap: £1.39b
CGEO Live PriceLast checked at - London Stock Exchange

Intraday Georgia Capital Share Chart

Director/PDMR Shareholding

29 Dec 2022 16:29

RNS Number : 2480L
Georgia Capital PLC
29 December 2022
 

London, 29 December 2022

 

 

 

Georgia Capital announces market purchase of shares for its Executive Equity Compensation Trust

 

Georgia Capital PLC (CGEO or the Group) was notified by Sanne Fiduciary Services Limited (Sanne), acting as trustee of the JSC Georgia Capital Executive Equity Compensation Trust (the Trust), that Sanne, through an independent broker, purchased in the market 65,791 CGEO ordinary shares with a nominal value of £0.01 each (Shares) at a price of £7.34 (rounded to two decimal points) per Share, traded on 29 December 2022 with a settlement date of 03 January 2023.

 

The Trust holds the Shares for the purpose of satisfying awards to be awarded to beneficiaries of the Trust. The executive directors and persons discharging managerial responsibility of the Group are potential beneficiaries under the Trust and are therefore treated as having an interest in such Shares. Upon settlement of the above transaction, the Trust will hold a total of 4,250,021 Shares, representing approximately 9.48% of CGEO's issued ordinary share capital.

 

Of the 4,250,021 Shares held by the Trust, 2,069,737 are allocated to existing awards.

 

 

Name of authorised official of issuer responsible for making notification: Link Company Matters Limited, Company Secretary

 

About Georgia Capital PLC

Georgia Capital is a platform for buying, building and developing businesses in Georgia with holdings in sectors that are expected to benefit from the continued growth and further diversification of the Georgian economy. The Group's focus is typically on larger-scale investment opportunities in Georgia, which have the potential to reach at least GEL 300 million equity value over 3-5 years from the initial investment and to monetise them through exits, as investments mature. Georgia Capital currently has the following portfolio businesses: (i) a retail (pharmacy) business, (ii) a hospitals business, (iii) an insurance business (P&C and medical insurance); (iv) a clinics and diagnostics business, (v) a renewable energy business (hydro and wind assets) and (vi) an education business; Georgia Capital also holds other small private businesses across different industries in Georgia; a 20.0% equity stake in the water utility business and a 20.3% equity stake (at 30-Sep-22) in LSE premium-listed Bank of Georgia Group PLC ("BoG"), a leading universal bank in Georgia.

JSC Georgia Capital has, as of the date hereof, the following credit ratings:

S&P Global

'B+'/FC & 'B+'/LC

Moody's

B1/CFR & B1/PDR

 For further information, please visit www.georgiacapital.ge or contact:

 

Irakli Gilauri

Giorgi Alpaidze

Michael Oliver

Shalva Bukia

Chairman and Chief Executive

Chief Financial Officer

Adviser to the Chairman & CEO

Head of Investor Relations

ir@gcap.ge

+995 322 005 000

+44 203 178 4034

+ 995 322 005 045

ir@gcap.ge

ir@gcap.ge

ir@gcap.ge

 


This news report is presented for general informational purposes only and should not be construed as an offer to sell or the solicitation of an offer to buy any securities

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHQKLFLLLLLFBV
Date   Source Headline
1st Apr 202510:56 amRNSTotal Voting Rights
31st Mar 20254:09 pmRNSTransaction in Own Shares
28th Mar 20255:18 pmRNSTransaction in Own Shares
28th Mar 202512:20 pmRNSCancellation of Treasury Shares
27th Mar 20254:05 pmRNSTransaction in Own Shares
26th Mar 20252:09 pmRNSTransaction in Own Shares
25th Mar 20255:18 pmRNSTransaction in Own Shares
24th Mar 20255:10 pmRNSTransaction in Own Shares
21st Mar 20255:08 pmRNSTransaction in Own Shares
21st Mar 20257:00 amRNSAnnual Financial Report
20th Mar 20255:25 pmRNSTransaction in Own Shares
19th Mar 20255:00 pmRNSTransaction in Own Shares
18th Mar 20252:32 pmRNSTransaction in Own Shares
17th Mar 20255:19 pmRNSTransaction in Own Shares
14th Mar 20255:27 pmRNSTransaction in Own Shares
14th Mar 20257:00 amRNSTransaction in Own Shares
13th Mar 20254:27 pmRNSHolding(s) in Company
13th Mar 20252:59 pmRNSHolding(s) in Company
13th Mar 202510:44 amRNSDirector/PDMR Shareholding
12th Mar 20255:02 pmRNSTransaction in Own Shares
12th Mar 20254:39 pmRNSDirector/PDMR Shareholding
11th Mar 20255:17 pmRNSTransaction in Own Shares
11th Mar 202512:13 pmRNSHolding(s) in Company (Correction)
11th Mar 202510:37 amRNSDirector/PDMR Shareholding
11th Mar 20257:51 amRNSUS$ 25m increase to the share buyback programme
10th Mar 20255:18 pmRNSTransaction in Own Shares
7th Mar 20255:02 pmRNSTransaction in Own Shares
6th Mar 20255:08 pmRNSTransaction in Own Shares
5th Mar 20255:17 pmRNSTransaction in Own Shares
4th Mar 20255:23 pmRNSTransaction in Own Shares
4th Mar 20254:51 pmRNSHolding(s) in Company
3rd Mar 20255:14 pmRNSTransaction in Own Shares
3rd Mar 20252:25 pmRNSTotal Voting Rights
28th Feb 20256:00 pmRNSDirector/PDMR Shareholding
28th Feb 20255:28 pmRNSTransaction in Own Shares
28th Feb 20252:13 pmRNSCancellation of Treasury Shares
27th Feb 20255:06 pmRNSTransaction in Own Shares
26th Feb 20255:17 pmRNSTransaction in Own Shares
25th Feb 20255:17 pmRNSTransaction in Own Shares
24th Feb 20255:41 pmRNSTransaction in Own Shares
21st Feb 20255:12 pmRNSTransaction in Own Shares
20th Feb 20255:17 pmRNSTransaction in Own Shares
19th Feb 20255:14 pmRNSTransaction in Own Shares
18th Feb 20255:26 pmRNSTransaction in Own Shares
18th Feb 20252:04 pmRNSNotice of Results
17th Feb 20255:07 pmRNSTransaction in Own Shares
14th Feb 20255:05 pmRNSTransaction in Own Shares
13th Feb 20255:20 pmRNSTransaction in Own Shares
13th Feb 20252:58 pmRNSHolding(s) in Company
12th Feb 20255:31 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.